224 related articles for article (PubMed ID: 22190492)
41. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
[TBL] [Abstract][Full Text] [Related]
42. Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors.
Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2018 Aug; 293(35):13401-13414. PubMed ID: 29997256
[TBL] [Abstract][Full Text] [Related]
43. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
Gill K; Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
[TBL] [Abstract][Full Text] [Related]
44. An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors.
Wright JD; Reuter CW; Weber MJ
J Biol Chem; 1995 May; 270(20):12085-93. PubMed ID: 7538132
[TBL] [Abstract][Full Text] [Related]
45. Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy.
Dowlati A; Nethery D; Kern JA
Mol Cancer Ther; 2004 Apr; 3(4):459-63. PubMed ID: 15078989
[TBL] [Abstract][Full Text] [Related]
46. Epidermal growth factor and estrogen act by independent pathways to additively promote the release of the angiogenic chemokine CXCL8 by breast tumor cells.
Haim K; Weitzenfeld P; Meshel T; Ben-Baruch A
Neoplasia; 2011 Mar; 13(3):230-43. PubMed ID: 21390186
[TBL] [Abstract][Full Text] [Related]
47. Prolonged EGFR signaling by ERBB2-mediated sequestration at the plasma membrane.
Offterdinger M; Bastiaens PI
Traffic; 2008 Jan; 9(1):147-55. PubMed ID: 17956594
[TBL] [Abstract][Full Text] [Related]
48. Targeting the dimerization of epidermal growth factor receptors with small-molecule inhibitors.
Yang RY; Yang KS; Pike LJ; Marshall GR
Chem Biol Drug Des; 2010 Jul; 76(1):1-9. PubMed ID: 20456371
[TBL] [Abstract][Full Text] [Related]
49. ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells.
Choi BK; Fan X; Deng H; Zhang N; An Z
Cancer Med; 2012 Aug; 1(1):28-38. PubMed ID: 23342251
[TBL] [Abstract][Full Text] [Related]
50. Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation.
Scheck RA; Lowder MA; Appelbaum JS; Schepartz A
ACS Chem Biol; 2012 Aug; 7(8):1367-76. PubMed ID: 22667988
[TBL] [Abstract][Full Text] [Related]
51. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities.
Couet J; Sargiacomo M; Lisanti MP
J Biol Chem; 1997 Nov; 272(48):30429-38. PubMed ID: 9374534
[TBL] [Abstract][Full Text] [Related]
52. Differential activation of ErbB receptors in the rat olfactory mucosa by transforming growth factor-alpha and epidermal growth factor in vivo.
Ezeh PI; Farbman AI
J Neurobiol; 1998 Nov; 37(2):199-210. PubMed ID: 9805267
[TBL] [Abstract][Full Text] [Related]
53. Epidermal growth factor contains both positive and negative determinants for interaction with ErbB-2/ErbB-3 heterodimers.
Stortelers C; van De Poll ML; Lenferink AE; Gadellaa MM; van Zoelen C; van Zoelen EJ
Biochemistry; 2002 Apr; 41(13):4292-301. PubMed ID: 11914075
[TBL] [Abstract][Full Text] [Related]
54. EGF receptor exposed to oxidative stress acquires abnormal phosphorylation and aberrant activated conformation that impairs canonical dimerization.
Filosto S; Khan EM; Tognon E; Becker C; Ashfaq M; Ravid T; Goldkorn T
PLoS One; 2011; 6(8):e23240. PubMed ID: 21853092
[TBL] [Abstract][Full Text] [Related]
55. EGFR forms ligand-independent oligomers that are distinct from the active state.
Byrne PO; Hristova K; Leahy DJ
J Biol Chem; 2020 Sep; 295(38):13353-13362. PubMed ID: 32727847
[TBL] [Abstract][Full Text] [Related]
56. Activation of EGFR/ERBB2 via pathways involving ERK1/2, P38 MAPK, AKT and FOXO enhances recovery of diabetic hearts from ischemia-reperfusion injury.
Akhtar S; Yousif MH; Chandrasekhar B; Benter IF
PLoS One; 2012; 7(6):e39066. PubMed ID: 22720029
[TBL] [Abstract][Full Text] [Related]
57. The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction.
Adak S; DeAndrade D; Pike LJ
J Biol Chem; 2011 Jan; 286(2):1545-55. PubMed ID: 21047778
[TBL] [Abstract][Full Text] [Related]
58. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
59. Role of threonine residues in regulation of the epidermal growth factor receptor by protein kinase C and mitogen-activated protein kinase.
Morrison P; Takishima K; Rosner MR
J Biol Chem; 1993 Jul; 268(21):15536-43. PubMed ID: 8393447
[TBL] [Abstract][Full Text] [Related]
60. Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family.
Arkhipov A; Shan Y; Kim ET; Dror RO; Shaw DE
Elife; 2013 Jul; 2():e00708. PubMed ID: 23878723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
